CAR-T Therapy in China — Access and Cost Considerations

CAR-T therapy in China for eligible blood cancers and selected indications: how access works for international patients and what drives cost.

7500+

patients treated
page_content_stats_1_stat_number
years of experience

50+

partner clinics

What the medical trip includes

  • 1

    Travel and documents

    Invitation letters, visa guidance, and medical paperwork for travel to China.

  • 2

    Clinic matching

    Shortlist hospitals by diagnosis, stage, method, and budget.

  • 3

    On-site coordination

    Appointments, interpreter support, and communication with the medical team.

Why patients choose us

  • OK

    Case-based plan

    Options are built from your reports, not a one-size package.

  • OK

    Cost ranges

    We explain what is typically included and billed separately.

  • OK

    International workflow

    Remote pre-check, English coordination, clear next steps.

How it works

  • 01

    Send medical records

    Diagnosis, recent tests, previous treatment, and your goals.

  • 02

    Compare options

    Receive clinic options, methods, timelines, and estimated budgets.

  • 03

    Travel and treatment

    We help with logistics and stay connected during care.

Treatment package costs

  • Standard package

    estimate on request

    Case review, clinic shortlist, diagnostics plan outline, treatment stay coordination, interpreter support

  • Extended package

    estimate on request

    Priority case handling, broader clinic options, longer stay coordination, dedicated manager, full travel support

Who this is for

  • International patients

    Patients from abroad seeking specialty care, second opinions, and structured medical travel support in China.

  • Families and caregivers

    Relatives arranging treatment for a loved one who need clear options, cost ranges, and logistics help.

  • Complex or advanced cases

    People exploring advanced protocols such as immunotherapy, proton therapy, or cellular programs when clinically appropriate.

Frequently asked questions

More about treatment in China

CAR-T and related cellular immunotherapies are available in selected Chinese programs for specific hematologic malignancies and, in limited settings, other indications under protocols. Eligibility, manufacturing timelines, and cost are major factors for international patients. Not every patient qualifies.
Home
Menu
Search
Info